Drugmaker earnings show continuing cost pressure (AP)

AP – Despite fourth-quarter earnings reports that appeared solid, large job cuts at AstraZeneca and a steep sales slide for Eli Lilly’s top-selling medicine offer foreboding reminders of the pharmaceutical industry’s uncertain future.

Leave a Reply